Zoll Medical (ZOLL +5.8%) surges at the open following strong FQ1 results which showed revenue from its LifeVest wearable defibrillator worn by patients at risk for sudden cardiac arrest, jumped 45% to $32.3M and now accounts for 20% of revenue. Zoll seems back on track after the strong quarter and Medicare's recent reversal of a decision to change its coverage policy.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Apr 19, 2012)
at MarketWatch.com (Apr 19, 2012)
at MarketWatch.com (Mar 14, 2012)
at MarketWatch.com (Mar 13, 2012)
at MarketWatch.com (Mar 12, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs